title: MDM2 SNP309 polymorphism is associated with lung cancer risk in women: A meta-analysis using METAGEN.
abstract: Lung cancer is the most common diagnosed malignancy and the leading cause of cancer-related mortality worldwide. Murine double minute 2 (MDM2) SNP309 polymorphisms have been reported to influence the risk of lung cancer. However, the published studies together with four subsequent meta-analyses have yielded contradictory results. To examine this inconsistency, we conducted a meta-analysis of 6,696 lung cancer cases and 7,972 controls from eight published case-control studies using METAGEN. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated with STATA software and used to assess the strength of the association. In the overall analysis, a significant association between MDM2 SNP309 polymorphism and lung cancer risk was observed (OR, 1.143; 95% CI, 1.047-1.247). Moreover, stratified by ethnicity, a significant association was found in Asians (OR, 1.260; 95% CI, 1.111-1.429), but not in Europeans. Subgroup analysis of gender, histology and smoking status suggested that the MDM2 SNP309 genotype was associated with increased lung cancer risk in women (OR, 1.282; 95% CI, 1.062-1.548) and never smokers (OR, 1.328; 95% CI, 1.119-1.575). No statistically significant association was observed in males and ever smoking population, and no association was found in subgroup analysis based on histology. In conclusion, the association between MDM2 SNP309 and lung cancer was statistically significant, particularly in Asians, women and never smoking population.
authors.affiliation: Department of Cardiothoracic Surgery, First Affiliated Hospital, Guangxi Medical University, Nanning, Guangxi;
authors.forename: Wenwu
authors.initials: W
authors.lastname: He
authors.forename: Jianxiong
authors.initials: J
authors.lastname: Long
authors.forename: Lei
authors.initials: L
authors.lastname: Xian
authors.forename: Feng
authors.initials: F
authors.lastname: Pang
authors.forename: Li
authors.initials: L
authors.lastname: Su
authors.forename: Shixiu
authors.initials: S
authors.lastname: Wei
authors.forename: Bo
authors.initials: B
authors.lastname: Wei
authors.forename: Yanling
authors.initials: Y
authors.lastname: Hu